Jun. 30 at 3:14 AM
$MDXH another thing that no one is talking about... mdxhealth is a compelling buyout target, and will be so even more if they get the billing issues figured out.
Assuming their guidance of roughly 112.5 million revenue a year, and a multiple of only 2x revenue, that would be an EV of
$225 million or
$4.40 a share.
Given they have the tech in place, distribution, etc. Its not a far fetched possibility.
